Literature DB >> 12918007

Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes.

A A Bamigboye1, J Morris.   

Abstract

BACKGROUND: Laboratory evidence in the 1940s demonstrated a positive role of placental hormones in the continuation of pregnancy. It was suggested that diethylstilbestrol was the oestrogen of choice for prevention of miscarriages. Observational studies were carried out with apparently positive results, on which clinical practice was based. This led to a worldwide usage of diethylstilbestrol despite controlled studies with contrary findings.
OBJECTIVES: To determine the effects of antenatal administration of oestrogens, mainly diethylstilbestrol, on high risk and unselected pregnancy as regards miscarriages and other outcomes. SEARCH STRATEGY: We searched the Pregnancy and Childbirth Group Specialised Register of controlled trials in November 2002. SELECTION CRITERIA: Randomised and quasi-randomised trials were included. DATA COLLECTION AND ANALYSIS: Both reviewers extracted data from the studies identified that met the selection criteria, and the data were analysed using the RevMan software. MAIN
RESULTS: Miscarriage, preterm labour, low birthweight and stillbirth or neonatal death were not positively influenced by the intervention (diethylstilbestrol) as compared to the control group. Diethylstilbestrol in utero exposure led to increased rate of miscarriage and preterm birth. There was also an increase in the numbers of babies weighing less than 2500 grams. The maternal outcome in terms of pre-eclampsia was not influenced. Exposed female offsprings have a non-significant trend towards more cancer of the genital tract and cancer other than of the genital tract. Primary infertility, adenosis of the vagina/cervix in female offsprings, and testicular abnormality in male offsprings were significantly higher in those exposed to diethylstilbestrol before birth. REVIEWER'S
CONCLUSIONS: There was no benefit with the use of diethylstilbestrol in preventing miscarriages. Both short and long-term adverse outcomes in exposed offsprings were demonstration of the harm that this intervention caused women and their offspring during its usage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918007      PMCID: PMC9039959          DOI: 10.1002/14651858.CD004353

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  35 in total

1.  Effect of stilbestrol on pregnancy compared to the effect of a placebo.

Authors:  J H FERGUSON
Journal:  Am J Obstet Gynecol       Date:  1953-03       Impact factor: 8.661

2.  Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls.

Authors:  A L Herbst; D C Poskanzer; S J Robboy; L Friedlander; R E Scully
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

3.  EFFECT OF ESTROGENS AND ANDROGENS ALONE AND IN COMBINATION WITH CHORIONIC GONADOTROPIN ON THE OVARY OF THE HYPOPHYSECTOMIZED RAT.

Authors:  R I Pencharz
Journal:  Science       Date:  1940-06-07       Impact factor: 47.728

4.  Infertility among daughters either exposed or not exposed to diethylstilbestrol.

Authors:  E K Senekjian; R K Potkul; K Frey; A L Herbst
Journal:  Am J Obstet Gynecol       Date:  1988-03       Impact factor: 8.661

5.  Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol (DES).

Authors:  W B Gill; G F Schumacher; M Bibbo
Journal:  J Reprod Med       Date:  1976-04       Impact factor: 0.142

6.  Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring.

Authors:  R H Kaufman; E Adam; E E Hatch; K Noller; A L Herbst; J R Palmer; R N Hoover
Journal:  Obstet Gynecol       Date:  2000-10       Impact factor: 7.661

7.  Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long-term follow-up of mothers.

Authors:  V Beral; L Colwell
Journal:  Br Med J       Date:  1980-10-25

8.  Effects on the menstrual cycle of in utero exposure to diethylstilbestrol.

Authors:  P P Hornsby; A J Wilcox; C R Weinberg; A L Herbst
Journal:  Am J Obstet Gynecol       Date:  1994-03       Impact factor: 8.661

9.  Self-reported allergy, infection, and autoimmune diseases among men and women exposed in utero to diethylstilbestrol.

Authors:  D D Baird; A J Wilcox; A L Herbst
Journal:  J Clin Epidemiol       Date:  1996-02       Impact factor: 6.437

10.  A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring.

Authors:  M P Vessey; D V Fairweather; B Norman-Smith; J Buckley
Journal:  Br J Obstet Gynaecol       Date:  1983-11
View more
  20 in total

1.  Regional variations in testicular cancer rates in Ireland.

Authors:  M Alsinnawi; M R Quinlan; S Deady; E A Kiely
Journal:  Ir J Med Sci       Date:  2010-11-19       Impact factor: 1.568

Review 2.  Pharmacologic and Environmental Endocrine Disruptors in the Pathogenesis of Hypospadias: a Review.

Authors:  Rajiv Raghavan; Megan E Romano; Margaret R Karagas; Frank J Penna
Journal:  Curr Environ Health Rep       Date:  2018-12

3.  Letter: evidence-based wound care in the UK: a response to David Leaper's editorial in International Wound Journal April 2009 6 (2).

Authors:  Sally Bell-Syer; Marian Brady; Julie Bruce; Nicky Cullum; Ruth Foxlee; Andrew Jull; David Margolis; Liz McInnes; Andre Nelson; Susan O'Meara; Dirk Ubbink
Journal:  Int Wound J       Date:  2009-08       Impact factor: 3.315

Review 4.  Recurrent miscarriage.

Authors:  Kirsten Duckitt; Aysha Qureshi
Journal:  BMJ Clin Evid       Date:  2011-02-01

Review 5.  Medical treatments for incomplete miscarriage (less than 24 weeks).

Authors:  James P Neilson; Gillian Ml Gyte; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

6.  Long-Term Follow-Up and Treatment of a Female With Complete Estrogen Insensitivity.

Authors:  Soumia Brakta; Lynn P Chorich; Hyung-Goo Kim; Laurel A Coons; John A Katzenellenbogen; Janet E Hall; Kenneth S Korach; Lawrence C Layman
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 7.  Bisphenol-A and disparities in birth outcomes: a review and directions for future research.

Authors:  N Ranjit; K Siefert; V Padmanabhan
Journal:  J Perinatol       Date:  2009-07-09       Impact factor: 2.521

Review 8.  Bed rest during pregnancy for preventing miscarriage.

Authors:  A Aleman; F Althabe; J Belizán; E Bergel
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 9.  Medical treatments for incomplete miscarriage.

Authors:  Caron Kim; Sharmani Barnard; James P Neilson; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

Review 10.  Miscarriage and occupational activity: a systematic review and meta-analysis regarding shift work, working hours, lifting, standing, and physical workload.

Authors:  Jens Peter Bonde; Kristian Tore Jørgensen; Matteo Bonzini; Keith T Palmer
Journal:  Scand J Work Environ Health       Date:  2012-12-12       Impact factor: 5.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.